EssilorLuxottica S.A. (ESLOF) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Instruments & Supplies Branche. Der Hauptsitz des Unternehmens ist in Paris, France. Der aktuelle CEO ist Francesco Milleri.
ESLOF hat IPO-Datum 2010-10-15, 153,498 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $110.83B.
EssilorLuxottica S.A. is a global leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses, operating across North America, Europe, Latin America, Asia, Oceania, and Africa. The company operates through five core segments: Wholesale (luxury and sports eyewear manufacturing and distribution), Retail (direct-to-consumer eyewear sales), Lenses and Optical Instruments (including premium brands like Varilux, Crizal, Transitions, and Eyezen), Equipment (digital surfacing and coating machines), and Sunglasses and Readers (non-prescription eyewear under brands such as Foster Grant, Reebok, and Disney). Beyond its branded portfolio, EssilorLuxottica maintains a network of 490 prescription laboratories and edging-mounting facilities that serve opticians, prescription laboratories, and eye care professionals worldwide. The company combines Essilor's lens technology expertise with Luxottica's eyewear distribution capabilities to deliver comprehensive vision care solutions across multiple market segments and price points.
